merger
AstraZeneca ‘rejects Pfizer bid’
April 22, 2014Research and Development, Sales and Marketing AstraZeneca, Byetta, Onglyza, Pfizer, Soriot, merger
AstraZeneca has rebuffed a £60 billion bid from Pfizer, according to media reports. Both companies have declined to comment on …
Forest sold to Actavis for $25 billion
February 18, 2014Sales and Marketing Actavis, CNS, Forest, acquisition, labs, merger, synergy
The rumours of a substantial deal for Forest have been proven true after Actavis announced this afternoon that it will …
GE makes $1 billion Thermo deal
January 7, 2014Sales and Marketing general electric, merger, thermo fisher
General Electric Company is to pay around $1.06 billion in a bid to boost its life sciences capability in pharma’s …
Roche rules out merger talk
October 18, 2013Sales and Marketing Cancer, Herceptin, Novartis, Roche, merger
Roche has dismissed talk of merging with fellow Swiss manufacturer Novartis as it revealed its results for the last three …
Analysts want AstraZeneca-AbbVie tie-up
June 20, 2012Sales and Marketing AbbVie, Abbott, AstraZeneca, merger
Analysts want Abbott’s new spin-off firm AbbVie to merge with the troubled AstraZeneca, saying it could give both firms future …
OSI resists Astellas and invites other offers
March 16, 2010Sales and Marketing Astellas, OSI, merger
A new takeover bid launched by Japanese pharma company Astellas for OSI Pharma has been rejected by the company’s board. …
Pharma mergers and acquisitions in 2009
December 22, 2009Research and Development, Sales and Marketing Abbott, GSK, J&J, JJ, M&A, MA, Novartis, Pfizer, Wyeth, generics, industry, merger, year in review
This year saw two ‘mega mergers’ in the sector, the acquisition of Wyeth by Pfizer and the reverse takeover of …
2-in-1: Merck and Schering-Plough
April 8, 2009Research and Development, Sales and Marketing Merck, Schering-Plough, merger, pharma
The Merck and Schering-Plough merger creates a new industry giant to challenge Pfizer in terms of its scale and annual …
The Pfizer-Wyeth merger
February 2, 2009Research and Development, Sales and Marketing Pfizer, Wyeth, merger, sales
Before the merger, Pfizer faced a significant contraction in sales. Datamonitor's analysis suggests that the company's sales were declining at …
Escape routes diminishing for Aventis
February 12, 2004Sanofi-Aventis, acqisition, merger
Aventis’ chances of sidestepping the hostile takeover bid from Sanofi-Synthelabo are looking increasingly less likely as the ‘alternative scenarios’ it …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
